1,447 results on '"Brunetti, Natale Daniele"'
Search Results
2. Multidisciplinary approach in cardiomyopathies: From genetics to advanced imaging
3. Endothelial Function Correlates With Pulmonary Pressures in Subjects With Clinically Suspected Pulmonary Hypertension
4. Magnetic resonance mapping for the assessment of cardiomyopathies and myocardial disease
5. Impact of Frailty on Outcome of Older Patients With Non-ST Elevation Acute Myocardial Infarction Who Undergo Percutaneous Coronary Intervention
6. Left ventricular reverse remodeling after combined ARNI and SGLT2 therapy in heart failure patients with reduced or mildly reduced ejection fraction
7. Risk prediction of major cardiac adverse events and all-cause death following covid-19 hospitalization at one year follow-up: The HOPE-2 score
8. Takotsubo syndrome outcomes predicted by thyroid hormone signature: insights from cluster analysis of a multicentre registry
9. Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients
10. The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic
11. Flow Mediated Dilation in Systemic Sclerosis: Association with clinical findings, capillaroscopic patterns and endothelial circulating markers
12. Statin therapy and outcome in Takotsubo syndrome patients: Results from the multicenter international GEIST registry
13. Renal resistance index independently predicts worsening of renal function after coronary angiography
14. Meta-regression analysis on the impact of medical therapy on long-term outcome in spontaneous coronary artery dissection
15. ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON)
16. Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender
17. Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure
18. Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT)
19. Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction
20. Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis
21. Combined peripheral and central ultrasound for the diagnosis of PAH‐SSc patients
22. Combined peripheral and central ultrasound for diagnosis of PAH-SSc patients.
23. Renal Arterial and Venous Doppler in Cardiorenal Syndrome: Pathophysiological and Clinical Insights
24. Male gender and outcome in Takotsubo syndrome
25. Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone
26. Happy Heart Syndrome: Frequency, Characteristics, and Outcome of Takotsubo Syndrome Triggered by Positive Life Events
27. Gender Differences in Takotsubo Syndrome
28. Electrocardiographic findings and mortality in covid-19 patients hospitalized in different clinical settings
29. Stepwise approach for diagnosis and management of Takotsubo syndrome with cardiac imaging tools
30. Cardiac magnetic resonance imaging in the evaluation and management of mitral valve prolapse – a comprehensive review.
31. Investigation of a Large Kindred Reveals Cardiac Calsequestrin (CASQ2) as a Cause of Brugada Syndrome.
32. How brachial access compares to femoral access for invasive cardiac angiography when radial access is not feasible: A meta-analysis.
33. Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study
34. De Novo p.Asp3368Gly Variant of Dystrophin Gene Associated with X-Linked Dilated Cardiomyopathy and Skeletal Myopathy: Clinical Features and In Silico Analysis
35. Neurological Disorders in Takotsubo Syndrome: Clinical Phenotypes and Outcomes
36. Age‐Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry
37. Safety and heart rate changes in Covid-19 patients treated with Remdesivir
38. Left Ventricle Noncompaction Phenotype: Cause or Consequence?
39. Disease-modifier Drugs in Patients with Advanced Heart Failure: How to Optimize Their Use?
40. Impact of 2020 SARS-CoV-2 outbreak on telemedicine management of cardiovascular disease in Italy
41. Causes of syncopal recurrences in patients treated with permanent pacing for bradyarrhythmic syncope: Findings from the SYNCOPACED registry
42. Baseline and incident hypochloremia in chronic heart failure outpatients: Clinical correlates and prognostic role
43. Concealed structural heart disease discovered at cardiac magnetic resonance in patients with ventricular extrasystoles from ventricular outflow tract and apparently normal hearts
44. Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches
45. Stroke and left atrial thrombi after cryoballoon ablation of atrial fibrillation: incidence and predictors. Results from a long-term follow-up
46. The Atrioventricular Coupling in Heart Failure: Pathophysiological and Therapeutic Aspects.
47. Beta-blockers and renin-angiotensin system inhibitors for Takotsubo syndrome recurrence: a network meta-analysis.
48. Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach?
49. Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization
50. Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.